Veklury (Remdesivir) Drug Vials Recalled for Glass Particulate Matter
Gilead Sciences is recalling Veklury (remdesivir) injection vials nationwide due to the presence of glass particulates detected during a customer complaint investigation. The affected lots are 2141001-1A and 2141002-1A with expiration date 01/2024.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall as stated in the source metadata. The presence of glass particulates in an intravenous injection product presents a risk of serious injury, meeting the Class I threshold for a drug recall.
Plain-English summary
Gilead Sciences, Inc. is recalling Veklury (remdesivir) for injection, 100 mg/vial, a prescription antiviral medication. The recall affects 53,473 single-dose vials distributed nationwide in the United States. The recall was initiated after investigation into a customer complaint confirmed the presence of glass particulates in the product.
The affected lots are 2141001-1A and 2141002-1A, with expiration date 01/2024. The product is manufactured by Gilead Sciences, Inc., Foster City, CA 94404, with NDC 61958-2901-2.
Healthcare providers and patients who have received or are in possession of affected vials should discontinue use immediately. Patients should contact their healthcare provider for guidance on alternative treatment options.
The recalled product
- Product
- VEKLURY (REMDESIVIR)
- Brand
- VEKLURY
- Manufacturer
- Gilead Sciences, Inc.
- Category
- Drug — Injectable / Antiviral
- Affected units
- 53,473
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: 2141001-1A
- 2141002-1A
- Exp. 01/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · VEKLURY
- SevereFDA Recalls Veklury Injection Vials for Presence of Glass Particles
FDA (Drugs) · 2024-10-09
Same manufacturer · Gilead Sciences, Inc.
See all →- ModerateGilead Recalls Emtriva Oral Solution Due to Defective Leaking Containers
FDA (Drugs) · 2014-11-05
- LowGilead Recalls Truvada Tablets Due to Silicone Rubber Particulates
FDA (Drugs) · 2014-10-15
- LowGilead Recalls Atripla Tablets Due to Foreign Silicone Particulates
FDA (Drugs) · 2014-03-05
- HighGilead Recalls AmBisome Injection Due to Potential Sterility Assurance Issues
FDA (Drugs) · 2013-07-31
- SevereGilead Recalls Vistide Injection Due to Particulate Matter
FDA (Drugs) · 2013-05-22
Same hazard · glass contamination
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Tangerine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Acetylcysteine Solution Due to Particulate Matter
FDA (Drugs) · 2026-08-26